vs

Side-by-side financial comparison of Align Technology (ALGN) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Align Technology is the larger business by last-quarter revenue ($1.0B vs $719.4M, roughly 1.4× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 10.8%, a 62.3% gap on every dollar of revenue. On growth, Align Technology posted the faster year-over-year revenue change (6.2% vs 3.1%). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 0.6%).

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandib...

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

ALGN vs DOC — Head-to-Head

Bigger by revenue
ALGN
ALGN
1.4× larger
ALGN
$1.0B
$719.4M
DOC
Growing faster (revenue YoY)
ALGN
ALGN
+3.1% gap
ALGN
6.2%
3.1%
DOC
Higher net margin
DOC
DOC
62.3% more per $
DOC
73.2%
10.8%
ALGN
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
0.6%
ALGN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALGN
ALGN
DOC
DOC
Revenue
$1.0B
$719.4M
Net Profit
$112.8M
$114.0M
Gross Margin
70.8%
Operating Margin
13.6%
17.4%
Net Margin
10.8%
73.2%
Revenue YoY
6.2%
3.1%
Net Profit YoY
21.0%
2406.4%
EPS (diluted)
$1.57
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALGN
ALGN
DOC
DOC
Q1 26
$1.0B
Q4 25
$1.0B
$719.4M
Q3 25
$995.7M
$705.9M
Q2 25
$1.0B
$694.3M
Q1 25
$979.3M
$702.9M
Q4 24
$995.2M
$698.0M
Q3 24
$977.9M
$700.4M
Q2 24
$1.0B
$695.5M
Net Profit
ALGN
ALGN
DOC
DOC
Q1 26
$112.8M
Q4 25
$135.8M
$114.0M
Q3 25
$56.8M
$-117.1M
Q2 25
$124.6M
$31.7M
Q1 25
$93.2M
$42.8M
Q4 24
$103.8M
$4.5M
Q3 24
$116.0M
$85.9M
Q2 24
$96.6M
$146.0M
Gross Margin
ALGN
ALGN
DOC
DOC
Q1 26
70.8%
Q4 25
65.3%
Q3 25
64.2%
58.6%
Q2 25
69.9%
60.2%
Q1 25
69.5%
61.1%
Q4 24
70.0%
60.3%
Q3 24
69.7%
60.0%
Q2 24
70.3%
60.6%
Operating Margin
ALGN
ALGN
DOC
DOC
Q1 26
13.6%
Q4 25
14.8%
17.4%
Q3 25
9.7%
9.2%
Q2 25
16.1%
5.7%
Q1 25
13.4%
7.7%
Q4 24
14.5%
-2.2%
Q3 24
16.6%
14.1%
Q2 24
14.3%
22.3%
Net Margin
ALGN
ALGN
DOC
DOC
Q1 26
10.8%
Q4 25
13.0%
73.2%
Q3 25
5.7%
-16.6%
Q2 25
12.3%
4.6%
Q1 25
9.5%
6.1%
Q4 24
10.4%
0.7%
Q3 24
11.9%
12.3%
Q2 24
9.4%
21.0%
EPS (diluted)
ALGN
ALGN
DOC
DOC
Q1 26
$1.57
Q4 25
$1.88
$0.16
Q3 25
$0.78
$-0.17
Q2 25
$1.72
$0.05
Q1 25
$1.27
$0.06
Q4 24
$1.40
$0.02
Q3 24
$1.55
$0.12
Q2 24
$1.28
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALGN
ALGN
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$1.1B
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$4.1B
$7.5B
Total Assets
$6.3B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALGN
ALGN
DOC
DOC
Q1 26
$1.1B
Q4 25
$1.1B
$467.5M
Q3 25
$1.0B
$91.0M
Q2 25
$901.2M
$89.4M
Q1 25
$873.0M
$70.6M
Q4 24
$1.0B
$119.8M
Q3 24
$1.0B
$180.4M
Q2 24
$761.4M
$106.9M
Total Debt
ALGN
ALGN
DOC
DOC
Q1 26
Q4 25
$9.8B
Q3 25
$9.1B
Q2 25
$9.0B
Q1 25
$8.9B
Q4 24
$8.7B
Q3 24
$8.6B
Q2 24
$8.6B
Stockholders' Equity
ALGN
ALGN
DOC
DOC
Q1 26
$4.1B
Q4 25
$4.0B
$7.5B
Q3 25
$4.0B
$7.6B
Q2 25
$3.9B
$7.9B
Q1 25
$3.8B
$8.2B
Q4 24
$3.9B
$8.4B
Q3 24
$3.9B
$8.6B
Q2 24
$3.8B
$8.8B
Total Assets
ALGN
ALGN
DOC
DOC
Q1 26
$6.3B
Q4 25
$6.2B
$20.3B
Q3 25
$6.2B
$19.6B
Q2 25
$6.2B
$19.8B
Q1 25
$6.1B
$19.8B
Q4 24
$6.2B
$19.9B
Q3 24
$6.4B
$20.0B
Q2 24
$6.2B
$20.2B
Debt / Equity
ALGN
ALGN
DOC
DOC
Q1 26
Q4 25
1.31×
Q3 25
1.20×
Q2 25
1.14×
Q1 25
1.08×
Q4 24
1.04×
Q3 24
1.00×
Q2 24
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALGN
ALGN
DOC
DOC
Operating Cash FlowLast quarter
$151.0M
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
1.34×
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALGN
ALGN
DOC
DOC
Q1 26
$151.0M
Q4 25
$223.2M
$1.3B
Q3 25
$188.7M
$315.0M
Q2 25
$128.7M
$363.5M
Q1 25
$52.7M
$279.4M
Q4 24
$286.1M
$1.1B
Q3 24
$263.7M
$318.2M
Q2 24
$159.8M
$316.2M
Free Cash Flow
ALGN
ALGN
DOC
DOC
Q1 26
Q4 25
$187.3M
$357.0M
Q3 25
$169.0M
Q2 25
$107.2M
Q1 25
$27.4M
Q4 24
$263.1M
$333.7M
Q3 24
$233.9M
Q2 24
$106.4M
FCF Margin
ALGN
ALGN
DOC
DOC
Q1 26
Q4 25
17.9%
49.6%
Q3 25
17.0%
Q2 25
10.6%
Q1 25
2.8%
Q4 24
26.4%
47.8%
Q3 24
23.9%
Q2 24
10.3%
Capex Intensity
ALGN
ALGN
DOC
DOC
Q1 26
Q4 25
3.4%
124.4%
Q3 25
2.0%
Q2 25
2.1%
Q1 25
2.6%
Q4 24
2.3%
105.6%
Q3 24
3.0%
Q2 24
5.2%
Cash Conversion
ALGN
ALGN
DOC
DOC
Q1 26
1.34×
Q4 25
1.64×
10.99×
Q3 25
3.33×
Q2 25
1.03×
11.48×
Q1 25
0.57×
6.52×
Q4 24
2.76×
235.43×
Q3 24
2.27×
3.71×
Q2 24
1.66×
2.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALGN
ALGN

Clear Aligner$856.0M82%
CAM Services$184.1M18%

DOC
DOC

Segment breakdown not available.

Related Comparisons